07-07-2023 | Type 2 diabetes | News
The TIMI Risk Score for Atherothrombosis in Diabetes categorises risk of myocardial infarction or stroke in people with type 2 diabetes.
06-21-2023 | Cardiovascular disorders | News
Real-world study data show that non-fasting remnant cholesterol levels are associated with a significantly increased risk for CVD in people without diabetes, with a similar, but nonsignificant, trend observed in those with diabetes.
04-24-2023 | Heart failure | News
A case-crossover study supports a link between use of non-steroidal anti-inflammatory drugs and development of heart failure in people with type 2 diabetes.
02-08-2023 | Heart failure | News
A meta-analysis suggests that glucagon-like peptide-1 receptor agonists may help prevent new-onset heart failure in people with type 2 diabetes.
12-20-2022 | Dapagliflozin | News
Click through to read more on this announcement
12-06-2022 | Empagliflozin | News
A prespecified analysis of EMPEROR-Preserved indicates benefits of empagliflozin for people with heart failure and mildly reduced or preserved left ventricular ejection fraction.
11-21-2022 | Cancer | News
Having type 2 diabetes increases a person’s risk for a cancer being already metastatic at the point of diagnosis, shows an EPIC analysis.
11-18-2022 | Dapagliflozin | News
People who have heart failure with preserved ejection fraction benefit from dapagliflozin irrespective of whether they have normal or impaired glucose metabolism, shows further analysis of DELIVER.